- Report
- May 2024
- 130 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Clinical Trials
- June 2024
- 180 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- June 2024
- 298 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- August 2024
- 200 Pages
Global
From €3521EUR$3,869USD£3,019GBP
- Report
- August 2024
- 150 Pages
Global
From €2538EUR$2,789USD£2,176GBP
- Report
- February 2024
- 468 Pages
Global
From €4368EUR$4,799USD£3,744GBP
- Report
- November 2022
- 154 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Report
- September 2021
- 258 Pages
Global
From €2503EUR$2,750USD£2,146GBP
€5006EUR$5,500USD£4,291GBP
- Report
- June 2022
- 1500 Pages
Global
From €3549EUR$3,900USD£3,043GBP
- Report
- May 2022
- 510 Pages
Global
From €2730EUR$3,000USD£2,341GBP
- Report
- February 2022
- 360 Pages
United States
From €3276EUR$3,600USD£2,809GBP
- Report
- March 2021
- 240 Pages
United States
From €2730EUR$3,000USD£2,341GBP
- Report
- December 2020
- 120 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- July 2020
- 1200 Pages
Japan
From €2730EUR$3,000USD£2,341GBP
- Report
- April 2018
- 168 Pages
Global
From €1251EUR$1,375USD£1,073GBP
€2503EUR$2,750USD£2,146GBP
- Report
- June 2022
- 191 Pages
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- September 2023
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2021
- 50 Pages
China
From €2366EUR$2,600USD£2,029GBP
- Report
- March 2023
- 115 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2022
- 115 Pages
Global
From €4095EUR$4,500USD£3,511GBP
Avastin is a drug used in the treatment of certain types of cancer. It is a monoclonal antibody that works by blocking the growth of new blood vessels that tumors need to grow. Avastin is used to treat a variety of cancers, including colorectal, lung, kidney, and ovarian cancer. It is also used to treat metastatic breast cancer. Avastin is administered intravenously and is often used in combination with other cancer treatments, such as chemotherapy and radiation therapy.
Avastin is a key drug in the oncology market, as it is used to treat a variety of cancers. It is one of the most widely used cancer drugs in the world, and is often used in combination with other treatments. Avastin is a valuable tool in the fight against cancer, as it can help slow the growth of tumors and prolong the lives of patients.
Some of the companies in the Avastin market include Roche, Merck, Pfizer, AstraZeneca, and Novartis. Show Less Read more
